Advertisement
Co Presented By
Co Presented By

EU regulator recommends suspension India-tested drugs

The European Medicines Agency said the recommendation was based on findings from an inspection that raised concerns about how GVK conducted studies at the Hyderabad site on behalf of the pharmaceutical companies.

Advertisement
FP Archives|Jan 23, 2015, 18:51:00 IST

London: Europe's drug regulator said today it had recommended the suspension of a number of drugs which were approved on the basis of clinical studies conducted at GVK Biosciences in Hyderabad, India.[caption id="attachment_29715" align="alignleft" width="380"]Representational image. Reuters Representational image. Reuters[/caption]The European Medicines Agency said the recommendation was based on findings from an inspection that raised concerns about how GVK conducted studies at the Hyderabad site on behalf of the pharmaceutical companies.The move follows a similar decision from state regulators in France, Germany, Belgium and Luxembourg in December to suspend the marketing approval of 25 generic drugs due to concerns over the quality of data from clinical trials conducted by the Indian firm.Reuters

Handpicked stories, in your inbox
Global stories. Indian perspective. Zero noise.
No Spam. Unsubscribe Any Time.
First Published:Jan 23, 2015, 18:51:00 IST
Advertisement
Advertisement
Trending Stories

No premium queues, 30-minute target: What changes for Indian passport applicants in UAE

Indian passport applicants in the UAE can now access passport, visa and attestation services through Alhind’s 16 centres, with no premium queues, a Dh19 service fee and a target of completing applications within 30 minutes
4 min read
Advertisement
Advertisement
Up Next